MacroGenics Inc.

05/07/2021 | Press release | Archived content

ASCO 2021 Poster MGC018 Phase 1 Dose Escalation Study

MacroGenics Inc. published this content on May 07, 2021, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on October 23, 2025 at 16:39 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]